Clinical trial
A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (TROPOS Study)
NCT05975905 is registered in ClinicalTrials.gov with Keros Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (TROPOS Study)
- Lead sponsor
- Keros Therapeutics, Inc.
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- October 17, 2023
- Completion date
- March 11, 2025
- Enrollment
- 113 (actual)
- Sites
- 55
Conditions
As the registry lists them; a condition with its own page is linked.